Skip to main content

Table 3 Perioperative outcomes

From: Total arterial revascularization in patients with acute myocardial infarction – feasibility and outcomes

Parameter

SV group *

n = 152

TAR group *

n = 98

p-value

Transfusions

 Erythrocytes

  Rate

116 (76)

56 (57)

< 0.001

  Amount (units)**

2 ± 2.6

1 ± 2.7

0.041

 Platelets

  Rate

56 (37)

35 (36)

0.86

  Amount (units)**

0 ± 1.0

0 ± 0.90

0.33

 Fresh frozen plasma

  Rate

45 (30)

22 (22)

0.21

  Amount (units)**

0 ± 2.0

0 ± 2.0

0.46

Re-thoracotomy for bleeding

9 (5.9)

3 (3.1)

0.30

Sternal wound healing impairment requiring surgical revision

4 (2.6)

4 (4.0)

0.52

 Superficial

2 (1.3)

3 (3.0)

 Deep

2 (1.3)

1 (1.0)

Duration of invasive ventilation (hours)**

14 ± 58

10 ± 73

0.61

Postoperative tracheostomy

11 (7.2)

5 (5.1)

0.30

New onset atrial fibrillation

29 (19)

10 (10)

0.059

Stroke (>Rankin1)

3 (2.0)

0

0.1

Acute kidney injury

KDIGO I

59 (40)

32 (33)

0.17

KDIGO II

11 (7.5)

4 (4.1)

KDIGO III

6 (3.9)

5 (5.1)

Postoperative dialysis

6 (3.9)

5 (5.1)

0.69

Postoperative length of ICU stay (hours)**

73 ± 81

46 ± 93

0.28

Postoperative length of hospital stay (days) **

10 ± 4.5

10 ± 3.4

0.58

30-day all-cause mortality

6 (4.5)

3 (3.4)

0.68

  1. Abbreviations: ECLS extracorporeal life support, KDIGO Kidney disease: improving global outcomes, SV saphenous vein grafts, TAR total arterial revascularization
  2. aContinuous variables: mean ± SD; categorical variables: n (%)
  3. bMedian ± SD